Our Network
The Global Asthma Network currently has 353 centres in 135 countries and aims to have centres in all countries in the world. The Global Asthma Network is currently taking expressions of interest from new centres. We are particularly interested in centres from these countries. Click here to see the map.
World Asthma Day 2018: Deaths preventable if reach of asthma medicines increased
Around the world an estimated 1,000 people a day die of asthma related conditions, with some 340 million affected by this common chronic disease In New Zealand more than 521,000 people are taking medicines for asthma - one in nine adults and one in seven children. It causes a death here every week. Read more
GAN Steering Group Meeting 2017
The GAN Steering Group held their annual meeting in Murcia, Spain, on 6 & 7 September 2017, where the main topic was analyses of data.Read more
UK research for African lung health partnered with GAN
The Liverpool School of Tropical Medicine has recently received two prestigious grants: MRC Global Challenges Research Fund (GCRF) for Lung Health in Africa across the Life Course led by Dr Kevin Mortimer and National Institute for Health Research (NIHR) Global Health Research Unit on Lung Health and Tuberculosis in Africa led by Professor Bertie Squire.Read more
Global Burden of Disease
The latest estimates from the Global Burden of Disease (GBD) study estimate that there were 3.6 million deaths from the two most common chronic respiratory diseases in 2015.Read more
GAN publication
Global Asthma Network survey suggests more national asthma strategies could reduce burden of asthma.Read more
Global Impact of Respiratory Disease
The second edition of the Global Impact of Respiratory Disease was recently published by the Forum of International Respiratory Societies, with a foreword from Nikolai Khaltaev.Read more
Global Asthma Report 2014
The Global Asthma Report 2014 was officially launched at the 45th Union World Conference on Lung Health in Barcelona on 30 October 2014 and is available from www.globalasthmareport.org
read more
Closing the world data gaps for asthma is a key activity of the Global Asthma Network
The Global Asthma Report 2014 was officially launched at the 45th Union World Conference on Lung Health in Barcelona on 30 October 2014 and is available from www.globalasthmareport.org
Governments should commit to research, intervention, and monitoring to reduce the burden of asthma in the world
Asthma is a public health priority as it is a chronic respiratory disease affecting 334 million people worldwide
Countries should monitor asthma hospital admissions in children and adults to identify trends in asthma over time
Hospital admissions need to be monitored to identify trends in asthma over time and prevent epidemics
Avoidable asthma deaths are still occurring due to inappropriate management of asthma
including over-reliance on reliever medication rather than preventer medication
Health professionals in all countries should regard frequent or severe recurrent wheezing in infancy as part of the spectrum of asthma
Controlled asthma imposes far less of an economic burden than non-controlled asthma
The yearly costs of poorly managed asthma are 56 billion in the US alone
All countries should have effective policy action on known, remediable causes of asthma such as parental smoking (for children) and occupational exposures
All countries should have national strategies and action plans to improve asthma management and reduce costs
Asthma management guidelines are an essential part of successfully managing asthma and promoting the delivery of quality asthma care
All countries should have a list of essential medicines for asthma including both inhaled corticosteroids and a bronchodilator
All asthma inhalers procured, distributed, and sold in countries should meet international quality standards
Guaranteed access to quality-assured essential asthma medicines is vital to improving asthma outcomes
Low-income countries need appropriately trained health professionals and health services organised to manage asthma
Asthma is a serious burden in low- and middle-income countries
Governments in low- and middle-income countries should make asthma a health priority
Asthma is an important NCD in all regions of the world, affecting people in non-affluent as well as affluent countries
Governments should include asthma in all actions from WHO Global Action Plan for NCDs
Funding and development partners
The Global Asthma Network received major funding from The International Union Against Tuberculosis and Lung Disease (The Union) from 2012-2015. It is also generously supported by funding from the following organisations:
- Australia
- Asthma Australia
- Woolcock Institute of Medical Research
- France
- Aix Marseille University
- Georgia
- Center of Allergy & Immunology, Tbilisi
- Latvia
- Riga Stradins University
- New Zealand
- The Asthma Foundation of New Zealand
- Auckland Asthma Charitable Trust
- Boehringer Ingelheim
- University of Auckland
- Spain
- University of Murcia
- Valencia University
- Sultanate of Oman
- The Oman Respiratory Society
- United Kingdom
- Liverpool School of Tropical Medicine
- London School of Hygiene and Tropical Medicine
- National Institute for Health Research
- St Georges University of London
- UK Medical Research Council